scox

Epic Bio to Present Preclinical Data at 28th International Annual Congress of the World Muscle Society

by

SOUTH SAN FRANCISCO, Calif. — September 28, 2023 — Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today announced an oral and poster presentation at the upcoming International Annual Congress of the World Muscle Society taking place October 3-7, 2023 in Charleston, South Carolina. Poster Title: “A … Read more

Epic Bio to Present at Upcoming BMO Biopharma Spotlight Series Event

by

SOUTH SAN FRANCISCO, Calif. — September 19, 2023 — Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today announced that Amber Salzman, Ph.D., chief executive officer, will participate in a panel discussion at the BMO Biopharma Spotlight Series: Latest Advances in Genome / Epigenome Editing virtual event. The panel, titled … Read more

Epic Bio Reports Discovery of Exceptionally Durable Gene Activators and Creation of Machine Learning Algorithm to Design New Activators

by

– Vast high-throughput screening study used to train unique machine learning algorithm to design synthetic activators – – Rational engineering produced activators that induce the most durable and mitotically stable gene activation reported to date – SOUTH SAN FRANCISCO, Calif. — September 14, 2023 — Epic Bio, a biotechnology company developing therapies to modulate gene expression … Read more